|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Tryton Medical, Inc. Presents Positive Data from More Than 900 Patients at TCT 2012 Conference in Miami
10/29/2012 2:40:33 PM
DURHAM, N.C.--(BUSINESS WIRE)--Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced the latest data from a pooled analysis of 905 patients treated with the Tryton Side Branch Stent.™ Results were presented last week in Miami, Fla., by Joanna J. Wykrzykowska, M.D., Ph.D., of the University of Amsterdam as part of a standing-room-only Transcatheter Cardiovascular Therapeutics (TCT) 2012 satellite symposium co-chaired by Professors Martin B. Leon, M.D., of Columbia University Medical Center in New York and Patrick W. Serruys, M.D., Ph.D., of Erasmus University, Rotterdam, Netherlands.
|
|
|
|
|
|
|
|
|
|
|